Skip to main content
Sign In

Home Future StudentsCurrent StudentsFaculty & StaffPatientsAlumni

 

Marilyn E. Levi, MD

Associate Professor

 

Phone: 720-848-0817
E-mail: Marilyn.Levi@ucdenver.edu
Address: University of Colorado
Anschutz Outpatient Pavilion
Infectious Diseases Group Practice, P.O. Box 6510, Mail Stop B-163
Aurora, Colorado 80045

Medical School
University of Texas Southwestern Medical School

 

Residency
Internal Medicine, Parkland Memorial Hospital/Dallas VA Medical Center

Fellowship
Infectious Diseases, Parkland Memorial Hospital/Dallas VA Medical Center

 

Dr. Marilyn E. Levi is Associate Professor of Medicine in the division of infectious diseases at the University of Colorado Denver and director of transplant infectious diseases. She received her Infectious Diseases training at the University of Texas Southwestern Medical Center. Her work focuses on  infectious complications related to solid organ and bone marrow transplantation, with a specific interest in viral infections including the treatment of multiresistant cytomegalovirus with novel agents, Epstein Barr virus and posttransplant lymphoproliferative disorder.  She also has an interest in West Nile Virus infections in transplant recipients.   She is a member of the Transplant Infectious Diseases Community of Practice of the American Transplant Society.  She is an abstract reviewer for the infectious diseases section of the American Transplant Congress and journals including Liver Transplantation, American Journal of Transplantation, Transplant Infectious Diseases, Clinical Infectious Diseases, Nutrition Guide for Clinicans, Infectious Diseases Section and Transplantation. She also attends on the transplant infectious diseases and general infectious diseases inpatient services and the outpatient Infectious Diseases Group Practice Clinic at the University of Colorado Denver Hospital, and is involved in clinical trials in the area of transplant infectious diseases and the AIDS Clinical Trial Group.

  1. Kleinschmidt-DeMasters BK, Marder B, Levi M et al. Naturally-Acquired West Nile Virus Encephalomyelitis in Transplant Recipients: Clinical, Laboratory, Diagnostic, and Neuropathological Features. Archives of Neurology 61:1210-1220, 2004

  2. Lindenfeld JA, Page RL, Zolty R, Shakar S, Levi M et al. Drug Therapy in the Heart Transplant Recipient. Circulation: 2005;111:1-4

  3. Levi ME, Mandava N, Chan L, Weinberg A, Olson J. Treatment of Multi-drug Resistant Cytomegalovirus Retinitis with Systemically Administered Leflunomide. Transplant Infectious Diseases. Transplant Infectious Diseases 2006:8:38-43

  4. Bowles D, Truesdale A, Trotter J, Levi M. Enterobacter Cancerogenus Bacteremia in a patient with poor dentition, cirrhosis and a variceal bleed. Journal of Clinical Gastroenterology 2006;40;456-57

  5. Campsen J, Hendrickson R, Bak T, Wachs M, Kam I, Russ P, Nash R, Levi M. Herpes Simplex in a Liver Transplant Recipient. Liver Transplantation 2006:12:1171-1173

  6. Humar A, Morris M, Blumberg E, Freeman R, Preksaitis J, Kiberd B, Schweitzer E, Ganz S, Caliendo A, Orlowski JP, Wilson B, Kotton C, Michaels M, Kleinman S, Geier S, Murphy B, Green M, Levi M, et al. Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ the Right Test? A Consensus Conference Report. American Journal of Transplantation 2010;10:889-899

  7. Kumar D, Michaels M, Morris M, Green M, Avery R, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr K, Martin S, Silveira F, Razonable R, Allen U, Levi M et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ Transplants: a multicentre cohort study. Lancet Infectious Diseases 2010;10:521-526

  8. Laffoon B, Crutchfield A, Levi M, Bower WA, Kuehnert M, Brooks JT et al. HIV transmission through transfusion – Missouri and Colorado, 2008. Morbidity and Mortality Weekly Report 2010;59(41):1335-1339

  9. Page RL, Mueller SW, Levi ME, Lindenfeld J. Pharmacokinetic drug-drug interactions Between calcineurin inhibitors and proliferation signal inhibitors with antimicrobial agents: Implications for therapeutic drug monitoring. J of Heart Lung Transplant 2011;30(2):124-135